Abiopharma

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

BD Reports Third Quarter Fiscal 2025 Financial Results

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

New Form 8-K - Elanco Animal Health Inc Filed: 2025-08-07 AccNo: 0001739104-25-000052 Size: 749 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Elanco Animal Health Inc. - Elanco Animal Health Reports Second Quarter 2025 Results

Elanco Animal Health Reports Second Quarter 2025 Results

Lillys oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity

New Form 10-Q - Zai Lab Ltd Filed: 2025-08-07 AccNo: 0001628280-25-038548 Size: 6 MB

Other Scheme of Arrangement: Minutes of the Extraordinary General Meeting and the Scheme Meeting held on 15 July 2025

New Form 8-K - Zai Lab Ltd Filed: 2025-08-07 AccNo: 0001628280-25-038547 Size: 406 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Prestige Consumer Healthcare Inc. Filed: 2025-08-07 AccNo: 0001295947-25-000029 Size: 7 MB

New Form 8-K - Privia Health Group, Inc. Filed: 2025-08-07 AccNo: 0001759655-25-000091 Size: 525 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - HAEMONETICS CORP Filed: 2025-08-07 AccNo: 0000313143-25-000058 Size: 9 MB

New Form 10-Q - Green Thumb Industries Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104519 Size: 10 MB

New Form 8-K - Prestige Consumer Healthcare Inc. Filed: 2025-08-07 AccNo: 0001295947-25-000027 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits